indazoles has been researched along with Lymph Node Metastasis in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 24 (88.89) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Balgetir, F; Er, MB; Gonen, M; Yildirim, N | 1 |
| Albuquerque, EV; Bastos, DA; Bonadio, RC; Cavalcante, A; Coelho, RF; Cordeiro, MD; Nahas, WC; Pontes, J; Sarkis, AS; Sierra, PS | 1 |
| Furuse, J; Kasuga, A; Kawai, K; Kobayashi, T; Nagashima, F; Naruge, D; Okano, N | 1 |
| Albiges, L; Barthélémy, P; Bouleftour, W; Chevreau, C; Culine, S; Espenel, S; Fizazi, K; Gravis, G; Guillot, A; Houede, N; Joly, C; Mahammedi, H; Meriaux, E; Negrier, S; Oriol, M; Pouessel, D; Roubaud, G; Tartas, S; Tinquaut, F; Vassal, C | 1 |
| Fukuda, H; Iizuka, J; Ishida, H; Ishihara, H; Kobayashi, H; Kondo, T; Okumi, M; Takagi, T; Tanabe, K; Yoshida, K | 1 |
| Kai, F; Nagata, M; Ozono, S; Sugiyama, T; Takayama, T | 1 |
| Bosenberg, M; De, SK; Feng, Y; Kluger, H; Lazova, R; Li, JL; Pellecchia, M; Rickert, R; Ronai, ZA; Ruller, C; Scortegagna, M | 1 |
| Attia, S; Caracciollo, JT; Conley, AP; Koplin, S; Reed, DR; Webber, NP | 1 |
| Choueiri, TK; Cleary, JM; Elfiky, AA; Gabriel, SB; Gandhi, L; Garraway, LA; Grabiner, BC; Hodis, E; Jacobus, S; Kantoff, PW; Lander, ES; Loda, M; Rosenberg, JE; Sabatini, DM; Shapiro, GI; Signoretti, S; Stack, EC; Stewart, M; Supko, JG; Taplin, ME; Van Allen, EM; Wagle, N | 1 |
| Aldabagh, B; Joo, J; Yu, SS | 1 |
| Bourlon, MT; Kessler, ER | 1 |
| Davis, ID; Deen, KC; Hawkins, RE; Sigal, E; Sternberg, CN | 1 |
| Bosenberg, M; Brown, K; Davies, MA; De, SK; Feng, Y; Halaban, R; Langdon, CG; Lau, E; Meeth, K; Pellecchia, M; Platt, JT; Ronai, ZA; Scortegagna, M; Sereduk, C; Stern, DF; Yin, H; Zhang, T | 1 |
| Agarwal, N; Carmichael, C; Deng, J; Figlin, RA; Jones, JO; Lau, C; Liu, X; Pal, SK; Pinnamaneni, M; Ruel, N; Twardowski, P; Vuong, W; Yu, H; Zhang, W | 1 |
| Bortlicek, Z; Buchler, T; Dusek, L; Fiala, O; Honzirkova, M; Kubackova, K; Melichar, B; Pavlik, T; Poprach, A; Slaby, O; Svoboda, M; Veskrnova, V; Vyzula, R; Zemanova, M | 1 |
| Jung, SH; Kang, WK; Kim, ST; Lee, J; Lee, SJ; Lim, HY; Park, JO; Park, SH; Park, YS | 1 |
| Angulo-Urarte, A; Baselga, J; Casanovas, O; Castel, P; Figueiredo, AM; Graupera, M; Martin, L; Milà-Guasch, M; Monelli, E; Soler, A; Viñals, F | 1 |
| Abe, H; Arai, K; Fukuda, T; Kamai, T; Masuda, A; Nukui, A; Yoshida, K | 1 |
| Campanario, R; Juárez, A; Saiz, R; Soto, M | 1 |
| Duffaud, F; Gelderblom, H; Grignani, G; Gronchi, A; Guida, M; Jones, RL; Kasper, B; Katz, D; Kollár, A; Litière, S; Marreaud, S; Safwat, A; Sleijfer, S; Stacchiotti, S; Steeghs, N; Touati, N; van der Graaf, WT | 1 |
| Hirabayashi, T; Tachibana, T; Takahashi, H; Watanabe, M | 1 |
| Arumugham, T; Burris, HA; Dar, MM; Dowlati, A; Fang, L; Gainer, SD; Hodge, JP; Infante, JR; Jones, SF; Lager, JJ; Nishioka, J; Suttle, AB; Tan, AR | 1 |
| Fujioka, T; Iwasaki, K; Obara, W | 1 |
| Ansell, P; Carlson, DM; Carr, BI; Chen, PJ; Dowell, B; Gill, S; Knox, JJ; McKeegan, EM; Pedersen, M; Qian, J; Qin, Q; Ricker, JL; Scappaticci, FA; Toh, HC; Yong, WP | 1 |
| Brugarolas, J; Jacobs, C; Kim, DW; Straka, C; Timmerman, RD | 1 |
| Bolte, O; Bukowski, RM; Bycott, P; Freddo, J; Hudes, GR; Kim, S; Liau, KF; Michaelson, MD; Motzer, RJ; Rini, BI; Rixe, O; Trask, PC; Wilding, G | 1 |
| Bardelli, D; Bertoni, F; Ciottoli, GB; Magno, L; Rosignoli, MT; Terraneo, F; Tordiglione, M | 1 |
2 review(s) available for indazoles and Lymph Node Metastasis
| Article | Year |
|---|---|
Fatal Acute Motor Axonal Neuropathy Induced by Nivolumab: A Case Report and Literature Review.
Topics: Aged; Antineoplastic Agents, Immunological; Axons; Carcinoma, Renal Cell; Drug Substitution; Fatal Outcome; Humans; Indazoles; Kidney Neoplasms; Lymphatic Metastasis; Male; Motor Neurons; Nivolumab; Paraparesis; Polyneuropathies; Pyrimidines; Skin Neoplasms; Sulfonamides | 2019 |
Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Benzamides; Biomarkers; Carcinoma, Merkel Cell; CD56 Antigen; Electrochemotherapy; Hepatitis A Virus Cellular Receptor 2; Humans; Imatinib Mesylate; Immunotherapy; Immunotherapy, Adoptive; Indazoles; Inhibitor of Apoptosis Proteins; Interferons; Interleukin-12; Interleukin-2; Ipilimumab; Lymphatic Metastasis; Membrane Proteins; Merkel cell polyomavirus; Oligonucleotides, Antisense; Piperazines; Polyomavirus Infections; Prognosis; Programmed Cell Death 1 Receptor; Pyrimidines; Receptors, Somatomedin; Skin Neoplasms; Somatostatin; Sulfonamides; Survivin; Thionucleotides; TOR Serine-Threonine Kinases | 2014 |
10 trial(s) available for indazoles and Lymph Node Metastasis
| Article | Year |
|---|---|
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases.
Topics: Adult; Aged; Antineoplastic Agents; Axitinib; Biliary Tract Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Imidazoles; Indazoles; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2017 |
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Administration Schedule; Everolimus; Female; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Mutation; Precision Medicine; Pyrimidines; Radionuclide Imaging; Sequence Analysis, DNA; Sulfonamides; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2014 |
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anorexia; Carcinoma, Renal Cell; Diarrhea; Disease-Free Survival; Female; Hair Color; Humans; Hypertension; Indazoles; Kaplan-Meier Estimate; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Pyrimidines; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2014 |
Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.
Topics: Aged; Axitinib; Disease-Free Survival; Humans; Imidazoles; Indazoles; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Vascular Endothelial Growth Factor Receptor-1 | 2015 |
Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Female; Follow-Up Studies; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Organoplatinum Compounds; Oxaliplatin; Prognosis; Prospective Studies; Pyrimidines; Stomach Neoplasms; Sulfonamides; Young Adult | 2016 |
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Follow-Up Studies; Hemangioendothelioma, Epithelioid; Hemangiosarcoma; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prognosis; Pyrimidines; Retrospective Studies; Sulfonamides; Survival Rate; Tunica Intima | 2017 |
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Indazoles; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Pyrimidines; Sulfonamides; Survival Rate; Tissue Distribution; Treatment Outcome | 2010 |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diarrhea; Disease-Free Survival; Fatigue; Female; Humans; Indazoles; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phenylurea Compounds; Treatment Outcome; Tumor Burden; Young Adult | 2013 |
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Axitinib; Bone Neoplasms; Carcinoma, Renal Cell; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Imidazoles; Indazoles; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Treatment Outcome | 2007 |
Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Time Factors | 1994 |
15 other study(ies) available for indazoles and Lymph Node Metastasis
| Article | Year |
|---|---|
Oncologic Outcomes in Young Adults With Kidney Cancer Treated During the Targeted Therapy Era.
Topics: Adolescent; Adult; Age Factors; Carcinoma, Renal Cell; Disease-Free Survival; Female; Follow-Up Studies; Humans; Indazoles; Kaplan-Meier Estimate; Kidney; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Risk Factors; Sulfonamides; Sunitinib; Young Adult | 2020 |
Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Carcinoma, Renal Cell; Denosumab; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Humans; Hypocalcemia; Indazoles; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prognosis; Pyrimidines; Retrospective Studies; Sulfonamides; Sunitinib | 2019 |
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indazoles; Kidney Neoplasms; Lymphatic Metastasis; Lymphocytes; Male; Molecular Targeted Therapy; Neutrophils; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Risk Assessment; Sorafenib; Sulfonamides; Sunitinib; Survival Rate | 2019 |
Axitinib controlled metastatic renal cell carcinoma for 5 years.
Topics: Aged; Antineoplastic Agents; Asian People; Axitinib; Brain Neoplasms; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Protein Kinase Inhibitors; Seizures; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Knockout Techniques; Humans; Indazoles; Lung Neoplasms; Lymphatic Metastasis; Melanoma, Experimental; Mice; Mice, Knockout; Mutation, Missense; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Skin Neoplasms; Tissue Array Analysis | 2014 |
Dramatic response to pazopanib in a patient with metastatic malignant granular cell tumor.
Topics: Aged; Female; Granular Cell Tumor; Humans; Indazoles; Lung Neoplasms; Lymphatic Metastasis; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome | 2014 |
What next? Choosing second-line therapy in progressive renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Prognosis; Pyrimidines; Radiography; Spinal Neoplasms; Sulfonamides | 2014 |
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.
Topics: Animals; Benzoates; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Immediate-Early Proteins; Indazoles; Lymphatic Metastasis; Melanoma; Mice, Knockout; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Skin; Skin Neoplasms | 2015 |
Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis.
Topics: Aged; Antineoplastic Agents; Bevacizumab; Carcinoma, Renal Cell; Disease-Free Survival; Female; Humans; Indazoles; Indoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Registries; Response Evaluation Criteria in Solid Tumors; Sorafenib; Sulfonamides; Sunitinib; Survival Rate; Treatment Outcome; Withholding Treatment | 2016 |
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors.
Topics: Animals; Antineoplastic Agents; Benzoxepins; Cell Line, Tumor; Cell Proliferation; Everolimus; Humans; Imidazoles; Indazoles; Liver; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Xenograft Model Antitumor Assays | 2016 |
Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Axitinib; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Renal Cell; CD28 Antigens; Chemotherapy, Adjuvant; Female; Humans; Imidazoles; Indazoles; Indoles; Kaplan-Meier Estimate; Karnofsky Performance Status; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Proteins; Nephrectomy; Preoperative Period; Prognosis; Pyrroles; Retrospective Studies; Sunitinib; Treatment Outcome; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A; Young Adult | 2016 |
[Complete response to tyrosine kinase inhibitors in metastatic renal cancer. Report of four cases].
Topics: Aged; Antineoplastic Agents; Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Remission Induction; Sunitinib | 2016 |
Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.
Topics: Aged, 80 and over; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Keratin-13; Keratin-17; Ki-67 Antigen; Lymphatic Metastasis; Mice, SCID; Tongue Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2017 |
Case of complete response to everolimus for metastatic renal cell carcinoma.
Topics: Abdominal Cavity; Acute Kidney Injury; Axitinib; Carcinoma, Renal Cell; Combined Modality Therapy; Everolimus; Humans; Imidazoles; Immunosuppressive Agents; Indazoles; Interferon-alpha; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Protein Kinase Inhibitors; Remission Induction; Sirolimus; Tomography, X-Ray Computed; Withholding Treatment | 2012 |
Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Renal Cell; Disease Progression; Drug Administration Schedule; Fatal Outcome; Humans; Indazoles; Kidney Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Nephrectomy; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome | 2013 |